Publication | Open Access
Reactogenicity and Immunogenicity of BNT162b2 in Subjects Having Received a First Dose of ChAdOx1s: Initial Results of a Randomised, Adaptive, Phase 2 Trial (CombiVacS)
25
Citations
0
References
2021
Year
No additional data available for this publication yet. Check back later!